Bedrijfsoverzicht
Northern Technologies International Corporation is a specialized developer and marketer of rust and corrosion inhibiting products, serving key markets in China, Brazil, India, the United States, and internationally through its ZERUST and Natur-Tec operating segments. The company operates within the Basic Materials sector, specifically targeting the Specialty Chemicals industry, where it focuses on providing protective chemical solutions for industrial applications. As of the latest available data, Northern Technologies International Corporation holds a market capitalization of $75.94M and generates annual revenue of $89.13M while employing a workforce of 269 individuals. These valuation and revenue figures indicate that the company functions as a small-cap entity with a niche operational scope, positioning it as a mid-tier player rather than a large-scale industrial conglomerate in the broader chemical landscape.
Financiële gezondheid
The company reported total revenue of $89.13M over the trailing twelve-month period, yet simultaneously recorded a net income loss of $-775,295, revealing a significant disconnect between top-line sales and bottom-line profitability that highlights substantial cost pressures or non-operational expenses eroding earnings. Despite the negative net income, the company maintains a positive EBITDA of $898,817, suggesting that core operational cash generation remains intact before interest, taxes, depreciation, and amortization. However, the free cash flow stands at $-3,802,665, indicating a notable cash burn rate that constrains immediate financial flexibility and necessitates reliance on existing cash reserves or external financing to fund operations. The gross margin is recorded at 37.0%, demonstrating a healthy markup on sales before operating expenses are deducted, whereas the operating margin is negative at -3.3%, signaling that overhead costs are exceeding gross profits. Furthermore, the profit margin of -0.9% confirms that the company is currently unprofitable on a net basis, which is consistent with the reported net income loss. On the balance sheet side, the company holds $6.47M in cash against $15.08M in total debt, resulting in a debt-to-equity ratio of 19.40 that suggests a leveraged capital structure where liabilities exceed equity holdings. Liquidity is supported by a current ratio of 1.81, indicating that current assets are more than double current liabilities, which provides a buffer for short-term obligations despite the net loss position. Management effectiveness is reflected in a return on equity of 0.4% and a return on assets of -0.6%, metrics that collectively demonstrate that the company is currently destroying value for shareholders and utilizing its asset base inefficiently in terms of generating positive returns.
Waarderingsbeoordeling
The valuation metrics present a mixed picture, with a trailing P/E ratio listed as N/A due to the lack of recent earnings, while the forward P/E is projected at 13.33, implying that the market anticipates a turnaround in profitability in the coming year. The price-to-book ratio stands at 1.05, indicating that the market values the company slightly above its book value, suggesting a neutral to slight premium over the net asset value of the equity. Additionally, the price-to-sales ratio is 0.85, and the EV/EBITDA stands at 99.00; these alternative metrics suggest that while sales multiples appear reasonable for a specialty chemical firm, the extremely high EV/EBITDA multiple reflects the market's pricing in of a significant future earnings recovery or the high cost of capital associated with the current negative earnings state. The stock's price volatility relative to the broader market cannot be quantified using beta as the value is listed as N/A, preventing a direct comparison of sensitivity to market movements. The 52-week high is $10.03 and the 52-week low is $6.75, meaning the current trading price sits somewhere within this established range, reflecting the uncertainty and potential for mean reversion in the share price given the alternating valuation multiples.
Growth & Income
The company achieved a revenue growth rate of 15.3% year-over-year, which is a positive indicator of market share expansion or successful product adoption, whereas earnings growth is listed as N/A due to the recent loss, preventing a direct comparison of earnings trajectory against sales growth. For dividend purposes, Northern Technologies International Corporation offers a dividend yield of 0.5% with a payout ratio of 71.0%, a situation that warrants scrutiny as paying nearly 71% of earnings to shareholders while reporting a net loss of $-775,295 suggests the dividend may be funded through cash reserves, debt, or retained earnings from prior profitable periods rather than current income. This high payout ratio in the context of negative net income indicates that the current dividend is likely unsustainable without a significant and sustained return to profitability, as the company is not generating current earnings to cover such a high proportion of distributions. The overall growth and income profile thus presents a dichotomy where top-line expansion is robust, but income generation is absent, and the dividend policy poses a risk to capital preservation given the fundamental earnings deficit.